Clinical trial
Clinical Trial in Males With BPH (Enlarged Prostate)
NCT00029822 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00029822 |
|---|---|
| Title | Clinical Trial in Males With BPH (Enlarged Prostate) |
| Official title | Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy |
| Intervention type | Drug |
| Interventions | Alfuzosin (SL770499) |
| Enrollment | 1,522 |
| Start date | May 1, 2001 |
| Completion | Mar 1, 2005 |
| First posted | Jan 24, 2002 |
| Last update posted | Jun 9, 2008 |
| Countries | Australia, Bulgaria, Canada, Denmark, Finland, Greece, Hungary, Israel, Netherlands, Norway, Poland, Portugal and 5 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: